Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Histamine in cancer immunology and immunotherapy. Current status and new perspectives
MP Sarasola, MA Taquez Delgado… - Pharmacology …, 2021 - Wiley Online Library
Cancer is the second leading cause of death globally and its incidence and mortality are
rapidly increasing worldwide. The dynamic interaction of immune cells and tumor cells …
rapidly increasing worldwide. The dynamic interaction of immune cells and tumor cells …
Histamine receptors and cancer pharmacology: an update
NA Massari, MB Nicoud… - British journal of …, 2020 - Wiley Online Library
In the present review, we will discuss the recent advances in the understanding of the role of
histamine and histamine receptors in cancer biology. The controversial role of the …
histamine and histamine receptors in cancer biology. The controversial role of the …
Understanding breast cancer: From conventional therapies to repurposed drugs
B Costa, I Amorim, F Gärtner, N Vale - European Journal of Pharmaceutical …, 2020 - Elsevier
Breast cancer is the most common cancer among women and is considered a developed
country disease. Moreover, is a heterogenous disease, existing different types and stages of …
country disease. Moreover, is a heterogenous disease, existing different types and stages of …
[HTML][HTML] Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets
PL Nguyen, J Cho - Biomolecules, 2021 - mdpi.com
High levels of histamine and histamine receptors (HRs), including H1R~ H4R, are found in
many different types of tumor cells and cells in the tumor microenvironment, suggesting their …
many different types of tumor cells and cells in the tumor microenvironment, suggesting their …
Eo771, is it a Well‐Characterized cell line for mouse Mammary cancer model? limit and uncertainty
A Le Naour, A Rossary, MP Vasson - Cancer medicine, 2020 - Wiley Online Library
Among mouse mammary tumor models, syngeneic cell lines present an advantage for the
study of immune response. However, few of these models are well characterized. The tumor …
study of immune response. However, few of these models are well characterized. The tumor …
Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases
Histamine exerts potent modulatory impacts on the cells of innate-[including neutrophils,
monocytes, macrophages, dendritic cells (DCs), natural killer (NK) cells and NKT cells] and …
monocytes, macrophages, dendritic cells (DCs), natural killer (NK) cells and NKT cells] and …
Mast cells and skin and breast cancers: a complicated and microenvironment-dependent role
Mast cells are important sentinel cells in host defense against infection and major effector
cells in allergic disease. The role of these cells in cancer settings has been widely debated …
cells in allergic disease. The role of these cells in cancer settings has been widely debated …
The antioxidant and immunomodulatory compound 3-[(4-chlorophenyl) selanyl]-1-methyl-1H-indole attenuates depression-like behavior and cognitive impairment …
AM Casaril, M Domingues, SR Bampi… - Brain, behavior, and …, 2020 - Elsevier
Psychiatric alterations are often found in patients with breast cancer even before the
initiation of adjuvant therapy, resulting in a poor quality of life. It has become accepted that …
initiation of adjuvant therapy, resulting in a poor quality of life. It has become accepted that …
Mast cell modulation of B cell responses: an under-appreciated partnership in host defence
AM Palma, MR Hanes, JS Marshall - Frontiers in Immunology, 2021 - frontiersin.org
Mast cells are well known to be activated via cross-linking of immunoglobulins bound to
surface receptors. They are also recognized as key initiators and regulators of both innate …
surface receptors. They are also recognized as key initiators and regulators of both innate …
The role of histamine and its receptors in breast cancer: from pathology to therapeutic targets
H Azimi, A Jafari, M Maralani, H Davoodi - Medical Oncology, 2024 - Springer
Breast cancer is the most common malignancy in women, and despite the development of
new treatment methods and the decreasing mortality rate in recent years, one of the clinical …
new treatment methods and the decreasing mortality rate in recent years, one of the clinical …